SNY – sanofi - american depositary shares (US:NASDAQ)

News

SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases [Yahoo! Finance]
NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program [Yahoo! Finance]
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs [Yahoo! Finance]
Cost Of Living Woes Fuelling Fake Medicine Demand In Nigeria [Barron's]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com